Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Randomized trials comparing multi-vessel percutaneous coronary intervention to coronary artery bypass grafting (CABG) have demonstrated the long-term superiority of CABG in diabetic patients. Benefits include improved survival, fewer recurrent myocardial infarctions and a lower risk of the need for repeat intervention. The focus of this review article is to review the contemporary management of diabetic patients with multi-vessel coronary artery disease.


Journal article


Curr Pharm Des

Publication Date





4589 - 4596


Coronary Artery Bypass, Coronary Artery Disease, Diabetic Angiopathies, Humans, Myocardial Infarction, Myocardial Revascularization, Percutaneous Coronary Intervention, Randomized Controlled Trials as Topic, Reoperation, Survival